| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |